SONIM TECHNOLOGIES INC
For the period ended Dec 31, 2023. Filed Mar 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 27, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the Consolidated Financial Statements
(In Thousands, except Share and Per Share Amounts)
NOTE 1—The Company and its significant accounting policies
Description of Business—Sonim Technologies, Inc. was incorporated in the state of Delaware on August 5, 1999, and is headquartered in San Diego, California. The Company is a leading provider of rugged and consumer durable mobile devices designed to provide extra protection for users who demand more durability in their work and everyday lives. Historically, the Company has focused on handsets and accessories in the enterprise and government sectors. However, the Company has increased its product portfolio to include connected devices including mobile hotspots that connect to the internet. In 2023, the Company has received five product awards from carriers in the U.S., Canada, and Australia, for two models of mobile hotspots that will launch in 2024. The Company has also expanded its portfolio of rugged phones to include a new semi-rugged smartphone that will be sold through the carriers to small business who want a more durable product. The Company has received three product awards from carriers for this new smartphone that will launch in 2024. The Company also received a product award for a consumer durable smartphone that will launch in the second half of 2024. In 2022, the Company began selling a tablet that was developed using the Company’s ODM model where the Company designs the product specifically for one customer and finds a manufacturer for that product. The tablet was a high volume and low margin product and generated a significant portion of the Company’s revenue in 2023. Sales of the tablet ended in October 2023 as the product reach its end of life. The ODM model is not a core business of the Company, and it is normal for ODM model revenue to fluctuate significantly.
Liquidity and Ability to Continue as a Going Concern—The Company’s consolidated financial statements account for the continuation of its business as a going concern. The Company is subject to the risks and uncertainties associated with the development and release of new products. The Company’s principal sources of liquidity as of December 31, 2023, consist of existing cash and cash equivalents totaling $9,397. The Company believes that it can meet its obligations with this cash over the next twelve months following the filing date of this report.
To provide additional liquidity to allow the Company to accelerate expansion into Europe and other markets, management is currently evaluating various funding alternatives and may seek to raise additional funds through issuances of equity, mezzanine or debt securities, or through arrangements with strategic or investment partners with greater sources of financing. The Company’s ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, the Company’s performance and investor sentiment with respect to the Company and its industry.
Financial Statement Presentation—The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for annual financial information.
Principles of Consolidation—The accompanying consolidated financial statements include the accounts of Sonim Technologies, Inc. and its wholly owned foreign subsidiaries, Sonim Technologies (INDIA) Private Limited, Sonim Technologies (Shenzhen) Limited, Sonim Technologies Shenzhen Limited Beijing Branch, Sonim Technologies (Hong Kong) Limited and Sonim Communications India Private Limited (collectively, the “Company”). All significant intercompany transactions and balances have been eliminated in consolidation.
Reclassifications—Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported results of operations.
Estimates—The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates include, but are not limited to, estimates related to revenue recognition; valuation assumptions regarding the determination of the fair value of common stock, as well as stock options; the useful lives of the Company’s long-lived assets; product warranties; loss contingencies; the recognition and measurement of income tax assets and liabilities, including uncertain tax positions; the net realizable value of inventory; and allowances for credit losses. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates. As of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require it to update its estimates, judgments or revise the carrying value of its assets or liabilities.
Concentrations of Credit Risk—The Company’s product revenues are concentrated in the technology industry, which is highly competitive and rapidly changing. Significant technological changes in the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s consolidated operating results.
Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited with high-quality, federally insured commercial banks in the United States and cash balances are in excess of federal insurance limits as of December 31, 2023 and 2022. On March 10, 2023, SVB was closed by the California Department of Financial Protection and Innovation, which appointed the FDIC as receiver. If any of the financial institutions with whom the Company does business were to be placed into receivership, then the Company may be unable to access the cash that it has on deposit with such institutions.
The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.
Segment Information—The Company operates in one reporting segment. Operating segments are defined as components of an enterprise about which separate financial information is evaluated regularly by the chief operating decision maker, who is the chief executive officer, in deciding how to allocate resources and assessing performance. The Company’s chief operating decision maker allocates resources and assesses performance based upon discrete financial information at the consolidated level.
**Cash and Cash Equivalents—**The Company considers all highly liquid investments with an original maturity from the date of purchase of 90 days or less to be cash equivalents. As of December 31, 2023, and 2022, cash and cash equivalents consist of cash deposited with banks and money market funds. Included in the Company’s cash and cash equivalents are amounts held by foreign subsidiaries. The Company had $1,131 and $1,061 of foreign cash and cash equivalents included in the Company’s cash positions on December 31, 2023 and 2022, respectively.
Accounts Receivable and Allowance for Credit Losses—Accounts receivable consist primarily of amounts due from customers in the course of normal business activities. Collateral on trade accounts receivable is generally not required. In June 2016, the FASB issued ASU 2016-13,Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires measurement and recognition of expected credit losses for financial assets held. This guidance is effective for interim and annual periods beginning after December 15, 2022. The Company adopted this guidance effective January 1, 2023. The adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements and primarily resulted in new disclosures. Under this guidance, the Company maintains an allowance for credit losses for estimated uncollectible accounts receivable. The allowance is based on the Company’s assessment of the economic health of its customers and its history of credit losses. Accounts are written off against the allowance account when they are determined to be no longer collectible.
Inventory—The Company reports inventories at the lower of cost or net realizable value. Cost is determined using a first-in, first-out method (“FIFO”) and includes the cost of inventory, materials, labor, and manufacturing overhead related to the purchase and production of inventories. Net realizable value is the estimated selling price in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation.
The Company periodically reviews its inventory for potential slow-moving or obsolete items and writes down specific items to net realizable value, as appropriate. The Company writes down inventory based on forecasted demand and technological obsolescence. These factors are impacted by market and economic conditions, technology changes, new product introductions, and changes in strategic direction, and require estimates that may include uncertain elements. Actual demand may differ from forecasted demand and such differences may have a material effect on recorded inventory values. Any write-down of inventory to the lower of cost or net realizable value creates a new cost basis that subsequently would not be marked up based on changes in underlying facts and circumstances.
Property and Equipment—Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the respective assets, generally 24 to 36 months. Leasehold improvements are amortized over the shorter of estimated useful lives of the assets or the lease term. Expenditures for repairs and maintenance are charged to expense as incurred. Upon disposition, the cost and related accumulated depreciation and amortization are removed from the accounts and the resulting gain or loss is reflected in the consolidated statements of operations.
Leases—The Company accounts for its leases under ASC 842, Leases. Under this guidance, arrangements meeting the definition of a lease are classified as operating or finance leases and are recorded on the Consolidated Balance Sheets as both a right of use asset and a lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company’s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right of use asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the right of use asset results in straight-line rent expense over the lease term. Variable lease expenses are recorded when incurred. In calculating the right of use assets and lease liabilities, the Company elects to combine lease and non-lease components. The Company excludes short-term leases having initial terms of 12 months or less from the new guidance as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term.
Non-recurring Engineering (“NRE”) Tooling and Purchased Software Licenses—Third-party design services relating to the design of tooling materials and purchased software licenses used in the manufacturing process are capitalized and included in other assets within the consolidated balance sheets. During the years ended December 31, 2023 and 2022, amortization of NRE tooling and NRE software costs approximating $12 and $13 were charged to Cost of Revenues. The related net book value is $110 and $13, respectively, as of December 31, 2023 and 2022.
Long-lived Assets—The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. No such impairments have been identified to date.
Revenue Recognition—The Company accounts for revenue in accordance with Accounting Standards Codification (“ASC”) 606,Revenue from Contracts with Customers.
The Company recognizes revenue primarily from the sale of products, including its mobile phones, tablets, and accessories. The Company also recognizes revenue from other contractual arrangements that may include a combination of products and NRE services or from the provision of solely NRE services.
Revenue recognition incorporates discounts, price protection and customer incentives. In addition to cooperative marketing and other incentive programs, the Company has arrangements with some distributors, which allow for price protection and limited rights of return, generally through stock rotation programs. Under the price protection programs, the Company gives distributors credits for the difference between the original price paid and the Company’s then current price. Under the stock rotation programs, certain distributors are able to exchange certain products based on the number of qualified purchases made during the period.
The Company’s handsets typically require a technical approval process. This process entails design and configuration activities required to conform the Company’s devices to a wireless carrier customer’s specific network requirements. Each wireless carrier defines its own specific functional requirements and certification process in order for the product to be ready for manufacture. While the technical approval process does involve some level of customization, in addition to design and configuration, the Company does not charge separately and is not reimbursed for these activities to the extent that they do not involve significant customization and does not incur these costs in advance of entering into binding agreements with its wireless carrier customers. Such technical approval is obtained prior to shipment. Revenue is recognized when control of promised goods or services is transferred to a customer in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To determine revenue recognition for its arrangements, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation.
Cost of Revenues—Cost of revenues includes direct and indirect costs associated with the manufacture of the Company’s products as well as with the performance of NRE services in connection with significant design modification and customization. Direct costs include the cost of inventory, shipping, royalties, warranty accruals, depreciation and amortization, supply chain costs, and logistic costs.
Advertising—The Company expenses the costs of advertising, including promotional expenses, as incurred. For the years ended December 31, 2023 and 2022 the Company hadno advertising expenses.
Shipping and Handling Costs—When the Company bills customers for shipping and handling it includes such amounts as part of revenue. Costs incurred for shipping and handling are recorded in cost of revenues.
Deferred Revenues—Deferred revenues represent the amount that is allocated to undelivered elements in multiple element arrangements. The Company limits the revenue recognized to the amount that is not contingent on the future delivery of products or services or meeting other specified performance conditions.
Research and Development—Research and development expenses consist of compensation costs, employee benefits, development fees paid to ODM partners, research supplies, allocated facility related expenses and allocated depreciation and amortization. Research and development expenses include costs incurred for the design and configuration activities of new products to conform to the specific functional requirements of the Company’s wireless carrier customers necessary to prepare the product for manufacture. The Company determined that the NRE technical approval costs and the NRE field test costs are contract fulfillment costs and recognizes the associated NRE asset as these costs are incurred. The Company tracks the NRE assets by product and customer, then amortizes the NRE assets to Cost of Revenues over a period of four years, which is management’s estimated average product life for each model phone, starting from the date of the first significant sales.
Stock-Based Compensation—The Company measures equity classified stock-based awards granted to employees, consultants, and directors based on the estimated fair value on the date of grant and recognizes compensation expense of those awards, net of actual forfeitures, on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. For awards subject to performance conditions, the Company evaluates the probability of achieving each performance condition at each reporting date and begins to recognize expense over the requisite service period when it is deemed probable that a performance condition will be met using the accelerated attribution method. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option pricing model, which is described more fully in Note 10. The fair value of each restricted stock award is measured as the fair value per share of the Company’s common stock on the date of grant.
Warranty—The Company provides standard warranty coverage on its accessories and handsets for one and three years, respectively, providing labor and parts necessary to repair the systems during the warranty period. The warranty coverage is an assurance type warranty, and thus is not a separate performance obligation. The Company accounts for the estimated warranty cost as a charge to cost of revenues when revenue is recognized. The estimated warranty cost is based on historical product performance and field expenses.
Utilizing actual service records, the Company calculates the average service hours and parts expense per system to determine the estimated warranty charge. The Company updates these estimated charges periodically. The actual product performance and/or field expense profiles may differ, and in those cases the Company adjusts warranty accruals accordingly.
From time to time, the Company ships mobile devices to its customers as seed stock. The seed stock represents extra units of mobile devices beyond the original mobile devices ordered by the customer and are primarily used to facilitate warranty coverage of mobile devices received by the Company’s customers from their direct customers.
The warranty liability account balance is based on management’s estimates of the lifetime return rate for each model and the cost to repair each returned model. These assumptions are based on historical rates for similar products and on actual return rates. If the estimated cost to repair each unit increased by 10%, then the warranty liability balance would be $52 higher at December 31, 2023. If the lifetime return rate was increased by 10%, then the warranty liability balance would be $52 higher at December 31, 2023. The cost of revenue for the year ended December 31, 2023 would increase by the same amount as an increase in the warranty liability. Decreases to these rates of 10% will reduce the warranty liability by the same amount.
Comprehensive Income or Loss—The Company had no items of comprehensive income or loss other than net loss for the years ended December 31, 2023 and 2022. Therefore, a separate statement of comprehensive loss has not been included in the accompanying consolidated financial statements.
Foreign currency translation—The Company uses the U.S. dollar as its functional currency for its significant subsidiaries. Foreign currency assets and liabilities are translated into U.S. dollars at the end-of-period exchange rates except for property and equipment, and related depreciation and amortization, which are translated at the historical exchange rates. Expenses are translated at average exchange rates in effect during each period. Foreign assets held directly by the Company include certain accounts receivable balances and bank accounts which are translated in the U.S. dollar at the end-of-period exchange rates. During the years ended December 31, 2023 and 2022, the Company had approximately $235 and $102, respectively, in net foreign currency transactions losses, which are included in Other Expense, Net, on the Consolidated Statements of Operations.
Sales taxes—Sales and value added taxes collected from customers and remitted to governmental authorities are accounted for on a net basis and not included in revenue.
Income taxes—The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.
Compliance with income tax regulations requires the Company to make decisions relating to the transfer pricing of revenue and expenses between each of its legal entities that are located in several countries. The Company’s determinations include many decisions based on management’s knowledge of the underlying assets of the business, the legal ownership of these assets, and the ultimate transactions conducted with customers and other third parties. The calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax regulations in multiple tax jurisdictions. The Company may be periodically reviewed by domestic and foreign tax authorities regarding the amount of taxes due. These reviews may include questions regarding the timing and amount of deductions and the allocation of income among various tax jurisdictions. In evaluating the exposure associated with various filing positions, the Company records estimated reserves when it is more likely than not that an uncertain tax position will not be sustained upon examination by a taxing authority. Such estimates are subject to change. See Note 11.
Net Loss per Share—Net loss per share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period. For the years ended December 31, 2023 and 2022, for purposes of the calculation of diluted net loss per share, warrants to purchase stock, unvested restricted stock units and stock options to purchase common stock are considered potentially dilutive securities but have been excluded from the calculation of diluted net loss per share as their effect is antidilutive. As a result, diluted net loss per share is the same as the basic net loss per share for the periods presented.
New accounting pronouncements—The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company, which is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.
Pronouncements not yet adopted:
In November 2023, the FASB issued ASU 2023-07,Segment Reporting (Topic 280):Improvements to Reportable Segment Disclosures. This ASU was issued to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. This guidance applies to all public entities that are required to report segment information in accordance with Topic 280, Segment Reporting. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted and the guidance should be applied retrospectively. ASU 2023-07 will be effective for the Company for the annual period of its fiscal year ending December 31, 2024. The Company does not anticipate the adoption of this guidance will have a material impact on its consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09*, Income Taxes*(Topic 740)*: Improvements to Income Tax Disclosures.*This ASU was issued to address investor requests for more transparency about income tax information through improvements to income tax disclosure primarily related to the rate reconciliation and income taxes paid information, and to improve the effectiveness of income tax disclosures. This guidance is effective for public entities for annual periods beginning after December 15, 2024. Early adoption is permitted. ASU 2023-09 will be effective for the Company in the first quarter of its fiscal year ending December 31, 2025. The Company is currently evaluating the impact the adoption of this guidance will have on its consolidated financial statements.
NOTE 2—Revenue recognition
The Company recognizes revenue primarily from the sale of products, including mobile phones, scanners, and accessories, and the majority of the Company’s contracts include only one performance obligation, namely the delivery of product. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is defined as the unit of account for revenue recognition under ASC 606. The Company also recognizes revenue from other contracts that may include a combination of products and NRE services or from the provision of solely NRE services. Where there is a combination of products and NRE services, the Company accounts for the promises as individual performance obligations if they are concluded as distinct. Performance obligations are considered distinct if they are both capable of being distinct and distinct within the context of the contract. In determining whether performance obligations meet the criteria for being distinct, the Company considers a number of factors, such as the degree of interrelation and interdependence between obligations, and whether or not the good or service significantly modifies or transforms another good or service in the contract. During the years ended December 31, 2023 and 2022, the Company did not have any contracts in which the products and NRE services were concluded to be a single performance obligation. In certain cases, the Company may offer tiered pricing based on volumes purchased for specific model phones. To date, all tiered pricing provisions have fallen into observable ranges of pricing to existing customers, thus, not resulting in any material right which could be concluded as its own performance obligation. In addition, the Company does not offer material post-contract support services to its customers.
Net revenue for an individual contract is recognized at the related transaction price, which is the amount the Company expects to be entitled to in exchange for transferring the goods and/or services. The transaction price for product sales is calculated as the product selling price net of variable consideration which may include estimates for marketing development funds, sales incentives, and price protection and stock rotation rights. The Company generally does not offer a right of return to its customers, except for certain distributors where the company estimates future returns and reduces revenue on sales subject to return and maintains a reserve for returns allowance. Typically, variable consideration does not need to be constrained as estimates are based on specific contract terms. However, the Company continues to assess variable consideration estimates such that it is probable that a significant reversal of revenue will not occur. The transaction price for a contract with multiple performance obligations is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices for products are determined based on the prices charged to customers, which are directly observable. The standalone selling price of the professional services are mostly based on time and materials. The Company determines its estimates of variable consideration based on historical collection experience with similar payor classes, aged accounts receivable by payor class, terms of payment agreements, correspondence from payors related to revenue audits or reviews, its historical settlement activity of audited and reviewed claims and current economic conditions using the portfolio approach. Revenue is recognized only to the extent that it is probable that a significant reversal of the cumulative amount recognized will not occur in future periods.
Revenue is then recognized for each distinct performance obligation as control is transferred to the customer. Revenue attributable to hardware is recognized at the time control of the product transfers to the customer. Control is generally transferred when the Company has a present right to payment and title and the significant risks and rewards of ownership of products or services are transferred to its customers. For most of the Company’s revenue attributable to hardware, control transfers when products are shipped. Revenue attributable to professional services is recognized as the Company performs the professional services for the customer.
Disaggregation of net revenues
The following table presents net revenues disaggregate by product category:
| Year Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Smartphones | $31,410 | $17,763 |
| Feature Phones | 15,765 | 21,252 |
| Tablets | 44,818 | 29,475 |
| Accessories/Other | 1,639 | 1,338 |
| Total Net Revenues | $93,632 | $69,828 |
Shipping and handling costs
The Company has elected to account for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products.
Contract costs
Applying the practical expedient, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred when the amortization period of the assets that otherwise would have been recognized is one year or less. These costs are included in sales and marketing and general and administrative expenses.
The non-recurring costs associated with design and development of new products for technical approval, represent costs to fulfill a contract pursuant to ASC 340-40,Other Assets and Deferred Costs. Accordingly, the Company capitalizes these non-recurring engineering costs and amortizes such costs over the estimated period of time over which they are expected to be recovered, which is typically four years, the estimated life of a particular model phone.
The total capitalized costs to fulfill a contract are primarily associated with the Company’s introduction of the XP10, XP5plus, and XP3plus model phones. As of December 31, 2023 and 2022, the total costs to fulfill a contract included in Contract Fulfillment Assets were $9,232 and $6,848, respectively.
Contract balances
The Company records accounts receivable when it has an unconditional right to consideration. As of December 31, 2023, and 2022, the Company does not have a contract receivable balance. Contract liabilities are recorded when cash payments are received or due in advance of performance. Contract liabilities consist of advance payments and deferred revenue, where the Company has unsatisfied performance obligations. Contract liabilities are presented as a component of Deferred Revenue on the Consolidated Balance Sheets. As of December 31, 2023 and December 31, 2022, the contract liabilities were $12 and $31, respectively, with the contract liabilities as of December 31, 2023, expected to be recognized into revenue in 2024.
The following table is a roll forward of contract liabilities:
| 2023 | 2022 | |
|---|---|---|
| Beginning Balance, January 1 | $31 | $11 |
| Recognition of revenue | (490) | (1,001) |
| Addition of revenue | 473 | 1,021 |
| Ending Balance, December 31 | $12 | $31 |
NOTE 3—Fair value measurement
The fair value measurements standard establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy under the standard are described below:
Level 1—Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.
Level 2—Inputs to the valuation methodology include:
| ● | Quoted market prices for similar assets or liabilities in active markets; |
| ● | Quoted prices for identical or similar assets or liabilities in inactive markets; |
| ● | Inputs other than quoted prices that are observable for the asset or liability; |
| ● | Inputs that are derived principally from or corroborated by observable market data by correlation or other means. |
If the asset or liability has a specified (contractual) term, the level 2 input must be observable for substantially the full term of the asset or liability.
Level 3—Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
The asset’s or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.
The following is a description of the valuation methodologies used for assets and liabilities measured at fair value. There have been no changes in the methodologies used for the years ended December 31, 2023 and 2022.
Money market funds are classified within level 1 of the fair value hierarchy because they are valued using quoted market prices.
The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.
The following tables sets forth by level, within the fair value hierarchy, the Company’s assets and liabilities at fair value:
| Level 1 | Level 2 | Level 3 | Total | |
|---|---|---|---|---|
| Assets: | ||||
| Money market funds * | $102 | $— | $— | $102 |
| Level 1 | Level 2 | Level 3 | Total | |
|---|---|---|---|---|
| Assets: | ||||
| Money market funds * | $1,501 | $— | $— | $1,501 |
| * | Included in cash and cash equivalents on the consolidated balance sheets. |
|---|
NOTE 4—Significant Balance Sheet Components
Inventory consisted of the following:
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Devices—for resale | $5,324 | $3,473 |
| Raw materials | 751 | 14 |
| Accessories | 442 | 423 |
| Inventory, Net | $6,517 | $3,910 |
The Company purchases raw materials in bulk to obtain a lower price. The raw materials are resold to third-party manufacturers at the Company’s cost.
Distributor returns allowance
The Company records reductions to revenue related to future distributor product returns based on the Company’s expectation. The Company had inventory related to distributor product returns totaling approximately $4 and $4, respectively, as of December 31, 2023 and 2022.
Prepaid expenses and other current assets consisted of the following:
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Deposits for manufacturing inventory | $197 | $— |
| Prepaid taxes | 361 | 433 |
| Refundable value added taxes | — | 45 |
| Prepaid licenses and royalties | 125 | 366 |
| Director and officer insurance | 272 | 250 |
| Prepaid parts (direct buy) | 77 | 193 |
| Prepaid consulting services | 110 | — |
| Other | 466 | 520 |
| Prepaid expenses and other current assets | $1,608 | $1,807 |
Property and equipment consisted of the following:
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Computer equipment | $156 | $412 |
| Software | 27 | — |
| Furniture, fixtures, and office equipment | 353 | 175 |
| Property and equipment, gross | 536 | 587 |
| Less: accumulated depreciation and amortization | (465) | (419) |
| Property and equipment, net | $71 | $168 |
Depreciation and amortization expense of property and equipment for the years ended December 31, 2023 and 2022, was $47 and $244, respectively. During 2022, the Company retired or disposed of computer equipment, software, and leasehold improvements with a cost of $4,751 and accumulated depreciation of $4,621 as the Company stopped manufacturing in 2022 and two U.S. leases were terminated. The Company recorded a loss on the disposal of assets of $130 on these disposals that is included in Other Expense, Net, in the Consolidated Statements of Operations.
Contract fulfillment assets are capitalized costs to test and obtain certification for cell phones and data devices with specific carriers. These costs are amortized over the estimated life of the device, which is four years. Contract fulfillment assets for the years ended December 31, 2023 and 2022 are $9,232 and $6,848 respectively. Amortization of contract fulfillment assets for the years ended December 31, 2023 and 2022 was $2,159 and $1,733, respectively.
Other assets consisted of the following:
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Advances to third-party manufacturer | $2,000 | $2,000 |
| Director and officer insurance | 408 | 525 |
| Deposits | 325 | 311 |
| Other | 165 | 136 |
| Total Other Assets | $2,898 | $2,972 |
Accrued liabilities consisted of the following:
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Customer allowances | $8,148 | $4,130 |
| Employee-related liabilities | 1,755 | 1,365 |
| Warranties | 518 | 636 |
| Accrual for goods received not invoiced | 325 | 301 |
| Contractual obligations | 59 | 1,107 |
| Royalties | 327 | 256 |
| Contract fulfillment costs | 568 | 1,469 |
| Credits due to customers | 122 | 961 |
| Returns allowance | 6 | 6 |
| Legal | 168 | 296 |
| Other | 237 | 165 |
| Accrued liabilities | $12,233 | $10,692 |
The table below sets forth the activity in the warranty liability, which is included in Accrued Liabilities on the Consolidated Balance Sheets:
| 2023 | 2022 | |
|---|---|---|
| Beginning Balance, January 1 | $636 | $836 |
| Additions | 1,057 | 1,493 |
| Cost of warranty claims | (1,175) | (1,693) |
| Ending Balance, December 31 | $518 | $636 |
NOTE 5—Accounts Receivable
The following table presents the components of the Company’s receivables:
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Trade receivables | $25,576 | $22,546 |
| Allowance for credit losses | (272) | (113) |
| Accounts receivable, net | 25,304 | 22,433 |
| Non-trade receivables | 961 | 2,269 |
| Total accounts receivable | $26,265 | $24,702 |
As of January 1, 2022, accounts receivable, net, was $10,803 and non-trade receivables was $2,255.
The Company has non-trade receivables from manufacturing vendors resulting from the sale of components to the vendors who manufacture and assemble final products for the Company.
During 2023, the Company implemented ASC 326 and accrued an allowance for credit losses. The Company determined the probability of default for each pool of receivables with similar risk characteristics. The probability of loss was applied to the value of the receivables and an allowance for potential credit losses was recorded with the offset to credit loss expense.
The following table displays the roll forward of the allowance for credit losses on the Company’s trade receivables during the year ended December 31, 2023:
| Beginning Balance, January 1, 2023 | $113 |
|---|---|
| Provision for credit losses | 159 |
| Ending Balance, December 31, 2023 | $272 |
Trade receivables from the customer that purchases tablets from the Company accounts for 69% and 84%, respectively, of accounts receivable, net, at December 31, 2023 and 2022. One additional customer accounted for 15% of accounts receivable, net, at December 31, 2023. In October 2023, the Company stopped sales of the tablets to this customer as the product reached the end of its life cycle. The tablet customer had a receivable due to the Company of $17,443 at December 31, 2023. In February 2024, an agreement was executed that transferred $11,308 of the receivables to the manufacturer of the tablets in exchange for relieving the Company of a $11,308 accounts payable liability. See Note 15.
NOTE 6—Leases
All of the Company’s leases are for office space. The Company entered into a sublease for a right of use asset in September 2021 that had sublease income that was significantly less than the head lease payments. On August 31, 2022, the Company entered into an agreement with the landlord to cancel the head lease for $260 in consideration paid by the Company to the landlord. On August 31, 2022, the Company derecognized the remaining lease liability and ROU asset. This resulted in a $730 gain on the termination of the lease. The sublease was terminated when the head lease was terminated.
The following table shows the activity of the ROU assets:
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Beginning Balance, January 1 | $66 | $— |
| Adoption of ASC 842 | — | 1,805 |
| Derecognition of deferred rent liability | — | (142) |
| Impairment of ROU asset | — | (978) |
| Derecognition on cancelation of lease | — | (221) |
| Additions | 255 | — |
| Amortization | (266) | (398) |
| Ending Balance, December 31 | $55 | $66 |
The following table shows the activity of the lease liability:
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Beginning Balance, January 1 | $66 | $— |
| Adoption of ASC 842 | — | 1,805 |
| Derecognition on cancelation of lease | — | (1,211) |
| Additions | 255 | — |
| Principal payments | (266) | (528) |
| Ending Balance, December 31 | 55 | 66 |
| Less short-term portion | 55 | 66 |
| Long-term lease liability | $— | $— |
Future minimum lease payments under noncancelable operating lease commitments were as follows as of December 31, 2023:
| 2024 | $56 |
| Total undiscounted minimum lease commitments | $56 |
| Effect of discounting | (1) |
| Lease liabilities at December 31, 2023 | $55 |
In connection with leases, for the year ended December 31, 2023 and 2022, the Company recognized $266 and $398, respectively, of rent expense. Variable lease payments, including reimbursements to the landlord for property taxes and operating expenses, of approximately $143 and short-term rent payments of $11 were included in rent expense for the year ended December 31, 2022, and were offset by $80 in sublease income. The Company does not have any lease extension or termination options on any lease. There are no residual value guarantees in any lease. The weighted average remaining lease term of the operating leases is approximately 0.2 years for the years ended December 31, 2023 and 2022. The weighted average of the discount rate for each lease as of December 31, 2023 and 2022 is 8.5%.
NOTE 7—Borrowings
Long-Term Debt
Promissory Notes Payable—In 2014 and 2017, the Company entered into agreements with one of its vendors, whereby certain of its trade payables for royalties and royalty up-front payments were converted to payment plans. In December 2018, the Company amended its accounts payable financing agreements, effective January 1, 2019, which provides for the $736 then-outstanding balance to be paid in twenty equal quarterly installments. The amounts due under these agreements were paid in quarterly installments over periods fromtwo tofour years, with interest ranging up to 8%. The entire balance was short term as of December 31, 2022 and was paid in full during the year ended December 31, 2023.
The components of the long-term debt balance were as follows as of December 31:
| 2023 | 2022 | |
|---|---|---|
| Promissory note payable | $— | $147 |
| Less current portion | — | (147) |
| Total long-term debt | $— | $— |
NOTE 8—Convertible Preferred Stock and Stockholders’ Equity
On November 2, 2018, the Company amended and restated its previous certificate of incorporation and adjusted its authorized capital stock (par value of $0.001) to consist of 100,000,000 shares of common stock and 5,000,000 shares of preferred stock. Each outstanding share of common stock entitles the holder to one vote on each matter properly submitted to the stockholders of the Company for vote. As of December 31, 2023, no shares of preferred stock have been issued.
The following table shows shares of common stock reserved as of:
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Shares subject to options to purchase common stock | 5,146,382 | 4,476,215 |
| Unvested restricted stock units | 681,846 | 860,888 |
| Shares subject to warrants to purchase common stock | 2 | 2 |
| Total | 5,828,230 | 5,337,105 |
NOTE 9—Stockholders’ Equity
On April 13, 2022, the Company entered into a subscription agreement (the “Subscription Agreement”) with AJP Holding Company, LLC (“AJP”) whereby, subject to the terms thereof, AJP agreed to purchase from the Company an aggregate of 20,833,333 shares of the Company’s common stock (the “Purchased Shares”) for a purchase price of $0.84 per share, for an aggregate purchase price of $17,500.
Pursuant to the terms and conditions set forth in the Subscription Agreement, the Purchased Shares were issued in two tranches: (i)14,880,952 shares of the Company’s common stock (the “Initial Shares”) was issued in consideration for an aggregate purchase price of $12,500 (“First Closing”) and (ii)5,952,381 shares will be issued for an aggregate purchase of $5,000.
The first closing was completed on July 13, 2022, and the second closing was completed on August 8, 2022.
In connection with the closings, the Company incurred approximately $3,130 of expenses which was offset against the proceeds in the third quarter of 2022.
Upon completion of the transaction, AJP controlled approximately 52% of Sonim’s post-transaction outstanding common stock. As of December 31, 2023, AJP controlled approximately 47% of Sonim’s outstanding common stock. The agreement with AJP also included a transition of the management team and the Company’s Executive Vice President for Global Operations and Engineering, who was appointed as Chief Executive Officer, effective April 14, 2022. The CEO is affiliated with the investment group at AJP. The Company continued to use the historical basis of assets and liabilities following the transaction.
On July 13, 2022, Robert Tirva, the CFO and President of the Company, resigned and became eligible for $1,000 in severance payments over 20 months, plus certain health insurance benefits, if he meets certain requirements. The severance costs were charged to expense as of the severance date. On July 13, 2022, approximately $1,200 in severance costs that were triggered by the AJP transaction were included in accrued expenses. On July 13, 2022, the Company appointed Clay Crolius as Chief Financial Officer.
On July 13, 2022, two of the Company’s Board Members resigned and the remaining Board of Directors appointed three new Board Members, including a representative of AJP. On July 14, 2022, the Board of Directors appointed two additional Board Members including Peter Liu, the Company’s Chief Executive Officer.
On September 23, 2021, the company entered into a Sales Agreement with the Sales Agent, to sell shares of its common stock, $0.001 par value per share, having an aggregate offering price of up to $41,637 from time to time, through a new at-the-market program (“ATM Program”). Under the terms of the Sales Agreement, the Company will pay the Sales Agent a commission equal to 3.0% of the gross proceeds from each sale of common stock sold through it under the Sales Agreement. From January 1, 2022, through January 4, 2022, the Company issued and sold an aggregate of 45,305 shares of its common stock at an average price per share of $0.99 under the ATM Program for net proceeds of approximately $45.
**NOTE 10—Stock-based Compensation **
As of December 31, 2023, the Company had the 2012 Equity Incentive Plan (the “2012 Option Plan”), 2019 Equity Incentive Plan (the “2019 Option Plan”) and the 2019 Employee Stock Purchase Plan (“ESPP”) in place.
The 2019 Option Plan provides for the grant of incentive and non-statutory stock options (“Options”), stock appreciation rights (“SAR”), restricted stock awards (“RSA”), and restricted stock unit awards (“RSU”) to employees, nonemployee directors, and consultants of the Company. Option awards granted under the 2019 Option Plan generally become exercisable ratably over atwo-year orfour-year period following the date of grant and expireten years from the date of grant. At the discretion of the Board of Directors, certain awards may be exercisable immediately at the date of grant but are subject to a repurchase right, under which the Company may buy back any unvested shares at their original exercise price in the event of an employee’s termination prior to full vesting. All other awards are exercisable only to the extent vested. At December 31, 2023 and 2022, there wereno shares that had been early exercised that were subject to the Company’s repurchase right at that date. The exercise price or strike price for Options and SARs granted under the 2019 Option Plan must generally be at least equal to 100% of the fair value of the Company’s common stock at the date of grant, as determined by the Board of Directors. The exercise price of incentive stock options granted under the 2019 Option Plan to ten percent or greater stockholders must be at least equal to 110% of the fair value of the Company’s common stock at the date of grant, as determined by the Board of Directors, and are not exercisable after five years from the date of grant.
The Board of Directors adopted, and its stockholders approved, the ESPP and the 2019 Option Plan in March 2019 and April 2019, respectively, each of which became effective in connection with the IPO. As of December 31, 2023, there were 158,337 shares of common stock available to be issued under the ESPP. The number of shares of common stock reserved for issuance under the ESPP automatically increases on January 1 of each calendar year for 10 years, starting January 1, 2020, and ending on, and including, January 1, 2029, in an amount equal to the lesser of 1% of the total number of shares of capital stock outstanding on December 31 st of the prior calendar year, and (ii) 50,000 shares, unless the Board of Directors or the compensation committee of the Board of Directors determines prior to such date that there will be a lesser increase, or no increase. The increase under the ESPP for both 2023 and 2022 was 50,000 shares. During 2022 and 2023, there were no purchases under the ESPP.
As of December 31, 2023, there were 1,843,128 shares of common stock available to be issued under the 2019 Option Plan, plus the number of shares subject to outstanding stock options or other stock awards that were granted under the 2012 Option Plan that are forfeited, terminated, expired or are otherwise not issued. Additionally, the number of shares of common stock reserved for issuance under the 2019 Option Plan automatically increases on January 1 of each calendar year for 10 years, starting January 1, 2020 and ending on and including January 1, 2029, in an amount equal to 5% of the total number of shares of capital stock outstanding on December 31 st of the prior calendar year, unless the Board of Directors or compensation committee determines prior to the date of increase that there will be a lesser increase, or no increase. The automatic increase under the 2019 Option Plan for the years ended December 31, 2023 and 2022 was 2,038,734 shares and 940,444 shares, respectively. In July 2022, the Board of Directors approved an increase in the number of shares of common stock reserved for future issuance under the 2019 Option Plan by 5,000,000 shares, which was approved by the Company’s stockholders on October 26, 2022. In August 2023, the Board of Directors approved an increase in the number of shares of common stock reserved for future issuance under the 2019 Option Plan by 2,000,000 shares, which was approved by the Company’s stockholders on September 28, 2023.
For the years ended December 31, 2023 and 2022, zero shares of common stock were issued under the 2019 Employee Stock Purchase Plan.
Stock-based compensation expense is as follows:
| For the Year Ended | ||
|---|---|---|
| December 31, | ||
| 2023 | 2022 | |
| Research and development | $84 | $18 |
| Sales and marketing | 377 | 68 |
| General and administrative | 934 | 1,426 |
| Cost of revenues | 101 | 39 |
| Total | $1,496 | $1,551 |
On January 27, 2022,415,023 shares of common stock were issued under the 2019 Option Plan as payment to three executives for bonuses that relate to the 2021 year. The dollar value of these bonuses was fixed at $254 as of December 31, 2021, and the number of shares issued on January 27, 2022 was determined based on the closing stock price on that date.
In the third quarter of 2022,385,599 shares of common stock were issued under the 2019 Option Plan as payment to consultants for consulting fees. The value of these shares was $260 at the time of issuance and $260 was recorded as General and Administrative expenses in the Consolidated Statements of Operations for the year ended December 31, 2022.
During the year ended December 31, 2023,457,354 shares of common stock were issued under the 2019 Option Plan as payment to consultants for consulting fees and 230,000 shares of common stock were issued outside of the Company’s stock plans as payment to consultants for consulting fees. The aggregate value of shares issued to consultants for consulting fees during the year ended December 31, 2023 was $498 at the time of issuance, $388 of which is included in General and Administrative expenses in the Consolidated Statements of Operations for the year ended December 31, 2023, and $110 of which is included in Prepaid Expenses and Other Current Assets in the Consolidated Balance Sheets as of December 31, 2023.
Stock Options:
Stock option activity for the years ended December 31, 2023 and 2022 is as follows:
| Weighted average exercise price · Weighted average remaining contractual life · Aggregate Intrinsic | ||||
|---|---|---|---|---|
| Options | per share | (in years) | Value* | |
| Outstanding at January 1, 2022 | 95,413 | $40.00 | 6.73 | $0 |
| Options granted | 4,414,419 | $0.44 | ||
| Options exercised | — | $— | ||
| Options forfeited | (15,303) | $33.65 | ||
| Options cancelled | (18,314) | $49.67 | ||
| Outstanding at December 31, 2022 | 4,476,215 | $0.95 | 9.76 | $358 |
| Options granted | 1,803,000 | $0.57 | ||
| Options exercised | (1,125,000) | $0.42 | ||
| Options forfeited | — | $— | ||
| Options cancelled | (7,833) | $4.50 | ||
| Outstanding at December 31, 2023 | 5,146,382 | $0.93 | 8.94 | $1,370 |
| Vested and expected to vest at December 31, 2023 | 5,146,382 | $0.93 | 8.94 | $1,370 |
| Exercisable at December 31, 2023 | 609,948 | $4.00 | 8.55 | $167 |
| * | The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the balance sheet date. |
|---|
On December 26, 2023, an employee exercised 125,000 stock options. The Company issued common stock related to the exercised stock options in January 2024.
As of December 31, 2023, there was approximately $1,395 of unamortized stock-based compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of 1.53 years.
The total pre-tax intrinsic value of options exercised during the year ended December 31, 2023 was $196. The intrinsic value is the difference between the estimated fair value of the Company’s common stock at the date of exercise and the exercise price for in-the-money options.
The weighted average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $0.57 and $0.40, respectively.
The fair value of stock options is determined using the Black-Scholes option-pricing model using various inputs, including the Company’s estimates of the fair value of common stock on the date of grant, expected term, expected volatility, risk-free interest rate, and expectations regarding future dividends. Stock-based compensation also reflects the Company’s estimate regarding the portion of awards that may be forfeited.
The following describes the key inputs used by the Company:
Fair Value of Common Stock—The Company measures equity classified stock-based awards granted to employees, consultants, and directors based on the estimated fair value on the date of grant, and the expense is recognized on a straight-line basis over the vesting period.
Expected Term—The expected term represents the period that the Company’s stock options are expected to be outstanding. The majority of stock option grants are considered to be “plain vanilla” and thus the Company determines the expected term using the simplified method. The simplified method deems the term to be the average of the time-to-vesting and the contractual life of the options.
Expected Volatility—The expected volatility was derived from the historical stock volatility of the Company’s common stock since its IPO in May 2019.
Risk-Free Interest Rate—The risk-free interest rate is based on the interest yield in effect at the date of grant for zero coupon U.S. Treasury notes with maturities approximately equal to the option’s expected term.
Dividend Rate—The expected dividend rate was assumed to be zero, as the Company has not previously paid dividends on common stock and has no current plans to do so.
Forfeiture Rate—Forfeitures are recognized when they occur. Historically, the Company estimated the forfeiture rate based on an analysis of actual forfeiture experience, analysis of employee turnover behavior, and other factors.
The following represents the weighted-average assumptions used in the Black-Scholes valuation model by the Company in calculating the fair value of each stock option granted during the year ended December 31, 2023:
| Expected dividend yield | 0% |
|---|---|
| Risk-free interest rate | 3.81% |
| Expected volatility | 114% |
| Expected life (in years) | 5.6 |
Restricted Stock Awards:
During 2022,385,599 restricted stock awards with a grant date value of $260 were awarded and released in exchange for consulting services. The expense was recorded in the Consolidated Statements of Operations as General and Administrative expenses.
During 2023,457,354 restricted stock awards with a grant date value of $305 were awarded and released in exchange for consulting services. The expense was recorded in the Consolidated Statements of Operations as General and Administrative expenses.
Restricted Stock Units:
The Company accounts for restricted stock units (“RSUs”) issued to employees and non-employees at fair value, based on the market price of the Company’s common stock on the date of grant. The RSUs are expensed over the vesting period, and the Company accounts for forfeitures as they occur. RSUs, primarily issued as incentives, generally vest annually over one to four years.
The following table summarized the outstanding RSUs as of December 31, 2023:
| RSUs | |
|---|---|
| Outstanding at January 1, 2022 | 860,888 |
| Granted | 445,200 |
| Released | (619,042) |
| Forfeited | (5,200) |
| Outstanding at December 31, 2023 | 681,846 |
As of December 31, 2023, there was approximately $391 of unamortized stock-based compensation cost related to unvested RSUs, which is expected to be recognized over a weighted average period of 1.15 years.
NOTE 11—Income Taxes
The following table presents the income (loss) before income taxes for domestic and foreign operations, and the components of the provision (benefit) for income taxes for the years ended December 31:
| 2023 | 2022 | |
|---|---|---|
| Domestic loss | $(425) | $(13,885) |
| Foreign subsidiaries income (loss) | 709 | (18) |
| Income (loss) before income taxes | $284 | $(13,903) |
| 2023 | 2022 | |
|---|---|---|
| Current income tax expense: | ||
| Federal | $2 | $— |
| State | 56 | 21 |
| Foreign | 250 | 306 |
| Total Current | 308 | 327 |
| Deferred income tax expense (benefit): | ||
| Federal | — | — |
| State | — | — |
| Foreign | 66 | (143) |
| Total Deferred | 66 | (143) |
| Total provision for income taxes | $374 | $184 |
The Company’s effective tax rate differs from the federal statutory rate due to the following for the years ended December 31:
| 2023 | 2022 | |
|---|---|---|
| Statutory federal income tax rate | 21.00% | 21.00% |
| State income taxes, net of federal tax benefits | 23.20% | 1.00% |
| Stock compensation | 84.92% | -1.43% |
| ASC 842 Adoption | 0.00% | 1.48% |
| Foreign rate differential | 58.55% | -1.20% |
| GILTI Inclusion | 26.15% | -0.17% |
| Non-deductible expenses | 1.02% | 0.00% |
| Valuation allowance | -83.07% | -22.00% |
| Effective tax rate | 131.77% | -1.32% |
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table presents the significant components of the Company’s deferred tax assets and liabilities at December 31:
| 2023 | 2022 | |
|---|---|---|
| Gross deferred tax assets: | ||
| Net operating loss carryforward | $18,887 | $18,937 |
| Section 174 capitalized costs | 1,873 | 1,697 |
| Tax credits | 100 | 99 |
| Accruals and reserves | 1,927 | 2,314 |
| Property and equipment | 21 | 51 |
| ASC 842 | 12 | 14 |
| Alternative minimum tax credits | 21 | 21 |
| Total gross deferred tax assets | 22,841 | 23,133 |
| Less: valuation allowance | (22,774) | (22,996) |
| Total deferred tax assets net of valuation allowance | 67 | 137 |
| Deferred tax liabilities: | ||
| ASC 842 right of use asset | (12) | (14) |
| Net deferred tax assets | $55 | $123 |
A valuation allowance is provided for deferred tax assets where the recoverability of the assets is uncertain. The determination to provide a valuation allowance is dependent upon the assessment of whether it is more likely than not that sufficient future taxable income will be generated to utilize the deferred tax assets. Based on the weight of the available evidence, which includes the Company’s historical operating losses, lack of taxable income, and the accumulated deficit, the Company provided a full valuation allowance against the U.S. deferred tax assets resulting from the accruals and reserves along with the net operating loss and credits carried forward.
As of December 31, 2023 and 2022 the Company had net deferred income tax assets related primarily to net operating loss carry forwards, accruals and reserves and tax credit carryforward that are not currently being recognized of $22,841 and $23,133, respectively, which have been offset by a valuation allowance.
The Company has not provided U.S. Federal and State income taxes, nor foreign withholding taxes on approximately $10,573 of undistributed earnings for certain non-US subsidiaries, because such earnings are intended to be indefinitely reinvested. If these earnings were distributed to the U.S. in the form of dividends or otherwise, or if the shares of the relevant foreign subsidiaries were sold or otherwise transferred, the Company would not be subject to U.S. income tax due to the transition tax of IRC Section 965 or via newly enacted Global Intangible Low-Taxed Income (“GILTI”) provision, enacted as part of the 2017 U.S. Tax Act. The Company would be subject to U.S. state tax and potential foreign withholding taxes on a repatriation of the foreign earnings. The amount of unrecognized deferred income tax liability related to these earnings is not material.
Estimate of cumulative foreign earnings is as follows as of December 31:
| 2023 | 2022 | |
|---|---|---|
| China | $5,471 | $5,031 |
| India | 5,102 | 5,098 |
| Total | $10,573 | $10,129 |
The Company had net operating loss carryovers as follows as of December 31:
| 2023 | 2022 | |
|---|---|---|
| Federal NOL | $88,066 | $88,375 |
| State NOL | $7,086 | $7,429 |
Net operating loss carryforwards are available to offset future federal and state taxable income. Federal and state net operating loss carryforwards begin to expire in 2037 and 2035, respectively. The net operating losses have annual Section 382 limitations.
The Company had research and development (“R&D”) credit carryforwards as follows as of December 31:
| 2023 | 2022 | |
|---|---|---|
| Federal R&D credits | $— | $— |
| California R&D credits | $127 | $125 |
Federal and state laws impose restrictions on the utilization of net operating loss carryforwards and R&D credit carryforwards in the event of a change in ownership of the Company, which constitutes an ‘ownership change’ as defined by Internal Revenue Code Section 382 and 383. The Company experienced an ownership change in the past that materially impacts the availability of its net operating losses and tax credits. The amounts indicated in the above tables reflect the reduction of net operating losses and credit carryforwards as a result of previous ownership changes that the Company experienced. Should there be additional ownership changes in the future, the Company’s ability to utilize existing carryforwards could be substantially restricted.
The Company had excess interest expense carryforwards of $1,333 as of December 31, 2023. Federal laws impose restrictions on the utilization of Section 163(j) excess interest expense carryforwards in the event of a change in ownership of the Company, which constitutes an ‘ownership change’ as defined by Internal Revenue Code Section 382 and 383. The Company experienced an ownership change in July 2022 that materially impacts the availability of its excess interest expense. However, since the Section 163(j) excess interest expense carryover does not expire, there will be no limitation under Section 382 against the excess interest expense carryover in 2023. Should the Company utilize the excess interest expense in the future, the availability of its carryforwards would be substantially restricted.
The Company has long-term income taxes payable primarily related to transfer pricing agreements with its foreign subsidiaries.
Uncertain Tax Positions
The Company accounts for uncertainty in income taxes in accordance with ASC 740,Income Taxes. Under ASC 740, uncertain tax positions are evaluated in a two-step process. The Company first determines whether it is more likely than not that a tax position will be sustained upon examination by the tax authority, including resolutions of any related appeals or litigation processes, based on technical merit. If a tax position meets the more-likely-than-not recognition threshold it is then measured to determine the amount of benefit to recognize, in the consolidated financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.
The following table summarizes the activity related to unrecognized tax benefits as follows as of December 31:
| 2023 | 2022 | |
|---|---|---|
| Unrecognized benefit-beginning of period | $1,273 | $1,306 |
| Gross increases-prior period tax positions | 1 | — |
| Gross (decreases)-prior period tax positions | — | (33) |
| Unrecognized benefit-end of period | $1,274 | $1,273 |
As of December 31, 2023, $1 of the unrecognized tax benefits are accounted for as a reduction in the Company’s deferred tax assets. Due to the Company’s valuation allowance, only $1,274 of the $1,273 of unrecognized tax benefits would affect the Company’s effective tax rate, if recognized. The Company does not believe it is reasonably possible that its unrecognized tax benefits will significantly change in the next twelve months.
The Company recognizes interest and penalties related to unrecognized tax benefits as income tax expense. The Company reported a tax expense of $45 of interest and penalties in 2023 and the Company has accrued a liability of $220 for accrued interest and penalties related to unrecognized tax benefit as of December 31, 2023.
The Company’s material income tax jurisdictions are the United States (federal and California), China and India. As a result of net operating loss and credit carryforwards, the Company is subject to audit for tax years 2014 and forward for California purposes and for 2017 and forward for federal tax purposes. The China and India tax years are open under the statute of limitations from 2017 and forward.
Accounting for GILTI requires companies to adopt tax accounting policies related to:
Treating the book-tax differences as either period costs or to recognize GILTI related deferred tax assets/liabilities in accounting for the GILTI book-tax differences. The Company has elected to treat this difference as a period cost.
In the Company’s valuation allowance analysis, the Company will elect the Increment Cash Tax Savings Approach in determining its U.S. valuation allowance.
NOTE 12 —Commitments and Contingencies
The terms and conditions of applicable bylaws, certificates or articles of incorporation, agreements or applicable law may obligate Sonim under certain circumstances to indemnify its current and former directors, officers or employees, and underwriters, with respect to certain of the matters described below and Sonim has been advancing legal fees and costs to certain current and former directors, officers, employees and underwriters in connection with certain matters described below.
Purchase Commitments—The aggregate amount of noncancelable purchase orders as of December 31, 2023 and 2022, was approximately $13,478 and $19,975, respectively, and were related to the purchase of inventory and components for the Company’s devices.
Royalty payments—The Company is required to pay per unit royalties to wireless essential patent holders and other providers of integrated technologies on mobile devices delivered, which, in aggregate, amount to less than 5% of net revenues associated with each unit and expire between 2025 and 2033. Royalty expenses for the years ended December 31, 2023 and 2022, were $1,102 and $622, respectively, which are included in Cost of Revenues on the Consolidated Statements of Operations. The Company may be required to pay additional royalties to additional patent holders and technology providers on future products.
General litigation—The Company is occasionally involved in various legal proceedings arising in the normal course of business. The Company is not involved in any material litigation as of the date of the filing of this Annual Report on Form 10-K.
The results of any future litigation cannot be predicted with certainty and, regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management time and resources and other factors.
Indemnification—Under the terms of its agreements with wireless carriers and other partners, the Company has agreed to provide indemnification for intellectual property infringement claims related to the Company’s product sold by them to their end customers. From time to time, the Company receives notices from these wireless carriers and other partners of a claim for infringement of intellectual property rights potentially related to their products. These infringement claims have been settled, dismissed, have not been further pursued by the customers, or are pending for further action by the Company.
Contingent severance obligations—The Company has agreements in place with certain key employees (Executive Severance Arrangements) guaranteeing severance payments under certain circumstances. Generally, in the event of termination by the Company without cause, termination due to death or disability, or resignation for good reason, the Company is obligated to the pay the employees in accordance with the terms of the agreements. On July 13, 2022, Robert Tirva, the CFO and President of the Company, resigned and became eligible for $1,000 in severance payments over 20 months, plus certain health insurance benefits, if he met certain requirements. The severance costs were charged to expense as of the severance date.
At the beginning of 2021, the Company outsourced substantially all of its software development to a third-party and transferred 105 employees to support the ongoing work to be performed. In connection with outsourcing its software development, the Company entered into an agreement of future business volume over the next three years. The agreement was renegotiated in 2022 and the remaining commitment as of December 31, 2023 and 2022 iszero and $1,154, respectively.
NOTE 13 —Net Loss Per Share
The following table sets forth the computation of the Company’s basic and diluted net loss per share:
| For the Years Ended | ||
|---|---|---|
| December 31, | ||
| 2023 | 2022 | |
| Numerator: | ||
| Net loss | $(90) | $(14,087) |
| Denominator: | ||
| Weighted-average shares used in computing net loss per share, basic and diluted | 41,689,386 | 28,889,111 |
| Net loss per share, basic and diluted | $(0.00) | $(0.49) |
The potentially dilutive common shares that were excluded from the calculation of diluted net loss per share because their effect would have been antidilutive:
| For the Years Ended | ||
|---|---|---|
| December 31, | ||
| 2023 | 2022 | |
| Shares subject to options to purchase common stock | 5,146,382 | 4,476,215 |
| Unvested restricted stock units | 681,846 | 860,888 |
| Shares subject to warrants to purchase common stock | 2 | 2 |
| Total | 5,828,230 | 5,337,105 |
NOTE 14 —Entity Level Information
Segment Information—The Company operates inone reporting segment.
Operating segments are defined as components of an enterprise about which separate financial information is evaluated regularly by the chief operating decision maker, who is the chief operating officer, in deciding how to allocate resources and assessing performance. The Company’s chief operating decision maker allocates resources and assesses performance based upon discrete financial information at the consolidated level.
The following table summarizes the revenue by region based on ship-to destinations for the periods ended:
| For the Years Ended | ||
|---|---|---|
| December 31, | ||
| 2023 | 2022 | |
| United States | $33,180 | $29,444 |
| Canada and Latin America | 10,572 | 8,975 |
| Europe and Middle East | 4,299 | 1,202 |
| Asia Pacific | 45,581 | 30,207 |
| Total net revenues | $93,632 | $69,828 |
Long-lived assets located in the United States and Asia Pacific region were $9,365 and $6,861, and $48 and $168 as of December 31, 2023 and 2022, respectively.
The composition of net revenues is as follows:
| For the Years Ended | ||
|---|---|---|
| December 31, | ||
| 2023 | 2022 | |
| Product Sales | $93,628 | $69,797 |
| Services | 4 | 31 |
| Total net revenues | $93,632 | $69,828 |
Concentrations of Revenue Risk—The Company’s tablet customer accounted for 48% and 42% of net revenues for 2023 and 2022, respectively. In the fourth quarter of 2023, tablet sales to this customer stopped as the product reached the end of its life cycle. After 2023, there is no longer a significant risk due to the concentration of revenue with this customer. One additional customer accounted for 29% and 25% of net revenues for 2023 and 2022, respectively.
NOTE 15—Subsequent Events
On February 6, 2024, the Company executed an agreement with its tablet customer and the manufacturer of the tablets to transfer$11,308 of the Company’s accounts receivable from the tablet customer to the tablet manufacturer in exchange for relieving the Company of a $11,308 accounts payable liability with the tablet manufacturer. If this agreement had been executed as of December 31, 2023, it would have resulted in a net$6,135 in accounts receivable to the Company as of December 31, 2023. As of March 27, 2024, $1,954 of the tablet customer’s accounts receivable balance has been paid to the Company.
On March 13, 2024, the Company received a notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that it has been granted a 180-day extension to regain compliance with the bid price for its common stock to close above $1.00 per share for ten consecutive trading days. The Company will take appropriate action that may include executing a reverse stock split to regain compliance with the minimum bid price rule if the Company’s stock does not stay above $1.00 prior to the end of the second 180-day period.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.